Know Your Risk Before It Strikes
Your arteries could be hiding early disease. Find out today.
Cardiac amyloidosis happens when abnormal proteins build up in the heart muscle and make it stiff. Treatment depends on the type. ATTR amyloidosis is treated with drugs that steady or reduce a protein called transthyretin. AL amyloidosis is treated with medicines that target abnormal plasma cells. There is no cure yet, but treatment can slow the disease and ease symptoms.
This content is for informational purposes only and is not medical advice. Amyloidosis is complex and needs a specialist. Never start, stop, or change a heart or cancer medicine without talking to your care team. If you have chest pain, fainting, or sudden trouble breathing, call emergency services. At BaleDoneen, we encourage patients to learn about their heart health and to bring good questions to their doctors.
ATTR vs AL: Why the Type Matters
The two main types are very different, even though both thicken the heart wall.
| Feature | ATTR amyloidosis | AL amyloidosis |
| Protein involved | Transthyretin, made in the liver | Light chains from plasma cells |
| Forms | Wild type (age related) or hereditary | Linked to a bone marrow disorder |
| Pace | Often slow | Can move fast |
| Treatment target | The TTR protein | The abnormal plasma cells |
Getting the right diagnosis comes first. Treating the wrong type can do harm. AL amyloidosis is urgent, and it needs a quick blood and urine workup. Heart imaging and other heart testing help confirm the type.
Treatment for ATTR Cardiac Amyloidosis
ATTR treatment falls into two groups. Chemotherapy is not a routine part of ATTR care.
TTR Stabilizers
Stabilizers keep the TTR protein from breaking apart and forming deposits.
- Tafamidis (Vyndaqel and Vyndamax) was approved by the FDA in 2019 and is taken once a day. In a major trial it lowered deaths and hospital stays compared with placebo.
- Acoramidis (Attruby) was approved in late 2024 and is taken twice a day. It also stabilizes TTR.
TTR Silencers
Silencers lower how much TTR protein the liver makes.
- Vutrisiran (Amvuttra) was approved in 2025 for ATTR cardiomyopathy. It is a small injection given under the skin about every three months. It works by a method called RNA interference.
Other silencers are used for hereditary ATTR with nerve damage, and drug labels change over time. Ask your specialist which drug fits your type of ATTR.
Treatment for AL Cardiac Amyloidosis
AL treatment aims to stop the plasma cells from making harmful light chains. Doctors in blood cancer care usually lead this.
- Daratumumab with hyaluronidase was the first FDA approved therapy for AL amyloidosis. It is usually combined with other drugs.
- Bortezomib based regimens are common. These often include cyclophosphamide and dexamethasone.
- Stem cell transplant helps selected patients who are strong enough for it. Heart damage can make this risky, so teams review each case closely.
When treatment works, light chain levels drop and organs may stabilize. Heart function may take months to improve.
Managing Heart Symptoms
Disease specific drugs do not fix every symptom. Supportive care matters.
Fluid and Heart Failure
Diuretics, also called water pills, remove extra fluid and ease swelling and breathlessness. Salt limits help. Some common heart failure drugs, such as beta blockers and certain blood pressure pills, are not well tolerated in amyloid hearts. Your doctor may adjust them. Good heart failure care supports every other treatment.
Atrial Fibrillation
AFib is common in amyloidosis. Clots can form even when the rhythm seems controlled, so blood thinners are often advised. Stroke risk is why blood thinners to prevent stroke are often discussed.
Conduction Disease and Pacemakers
The disease can slow the heart’s electrical signals. Some people need a pacemaker. A pacemaker treats slow rhythms, which is different from whether a pacemaker prevents a heart attack.
Low Blood Pressure and Fainting
Standing up can make you dizzy. Rise slowly, stay hydrated as allowed, and tell your doctor about fainting.
Daily Life With Cardiac Amyloidosis
Treatment works best with good daily habits. Weigh yourself each morning and report fast gains, since they can signal fluid buildup. Limit salt as your team advises. Keep a list of your medicines and bring it to every visit. Tell your doctor about numbness, tingling, or carpal tunnel symptoms, because these can be linked to ATTR. Regular visits allow your team to track heart tests and blood markers over time. Family members may also want to ask about screening if your type is hereditary.
New and Emerging Treatments
Researchers are testing drugs that clear amyloid deposits already in the heart, along with gene editing methods that aim to stop TTR production. These are not yet standard care. Ask about clinical trials at an amyloidosis center. Do not try unproven products sold online.
Costs and Side Effects
Newer ATTR drugs are expensive. List prices run from about $268,000 a year for tafamidis at launch to about $477,000 a year for vutrisiran. Insurance coverage, prior approval, and patient assistance programs make a big difference. Ask a social worker or pharmacist for help.
Side effects differ. Stabilizers are generally well tolerated, though some people have stomach upset. Vutrisiran may cause joint pain or injection site reactions. AL treatments can cause low blood counts, nerve problems, infections, and fluid shifts. Your team will monitor blood work and heart tests.
Outlook
Outcomes vary a lot. Early diagnosis helps, since treatment works best before heavy damage. ATTR often progresses slowly, while untreated AL with heart involvement can worsen quickly. No doctor can promise a result for any single person. Ask your team what to expect for your case, and how often you will be checked.
Frequently Asked Questions
Can cardiac amyloidosis be cured?
No cure exists. Treatment slows the disease and helps symptoms.
What is the difference between ATTR and AL?
ATTR comes from the TTR protein. AL comes from abnormal plasma cells.
Is chemotherapy used for ATTR?
No. Plasma cell directed therapy is for AL.
What are TTR stabilizers?
Drugs such as tafamidis and acoramidis that keep TTR from forming deposits.
What is a TTR silencer?
A drug such as vutrisiran that lowers TTR production.
Do I need a pacemaker?
Some people do, if the heart rate becomes too slow.
Can I exercise?
Light activity is often fine. Ask your specialist for safe limits. General advice on whether exercise lowers stroke risk can help, but ask your specialist first.
Questions to Ask Your Specialist
- Which type of amyloidosis do I have, and how was it confirmed?
- Should family members be tested for a hereditary form?
- Which treatment fits my type and stage?
- What side effects should I watch for?
- How will we measure whether treatment is working?
- Do I qualify for a clinical trial?
- Do I need a blood thinner or pacemaker?
- What will this cost and what help is available?
Key Takeaways
The right treatment depends on the exact type. ATTR uses stabilizers or silencers. AL uses plasma cell directed therapy. Supportive care for fluid, rhythm, and blood pressure matters too. Work with an amyloidosis center, and bring your questions. To protect the rest of your heart, ask about a heart attack prevention program.
About the Author: Christine Cooper
